Biomerieux SA
PAR:BIM

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
PAR:BIM
Watchlist
Price: 119.1 EUR -0.42% Market Closed
Market Cap: 14.1B EUR

Wall Street
Price Targets

BIM Price Targets Summary
Biomerieux SA

Wall Street analysts forecast BIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIM is 128.23 EUR with a low forecast of 90.9 EUR and a high forecast of 147 EUR.

Lowest
Price Target
90.9 EUR
24% Downside
Average
Price Target
128.23 EUR
8% Upside
Highest
Price Target
147 EUR
23% Upside
Biomerieux SA Competitors:
Price Targets
ATEC
Alphatec Holdings Inc
47% Upside
CEVI
CellaVision AB
29% Upside
228670
Ray Co Ltd
13% Downside
041830
InBody Co Ltd
46% Upside
2190
Zylox-Tonbridge Medical Technology Co Ltd
2% Downside
7817
Paramount Bed Holdings Co Ltd
9% Upside
6823
Rion Co Ltd
47% Upside
SHL
Siemens Healthineers AG
31% Upside

Revenue
Forecast

Revenue Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's revenue is 8%. The projected CAGR for the next 3 years is 8%.

8%
Past Growth
8%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's operating income is 11%. The projected CAGR for the next 3 years is 14%.

11%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

12%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIM's stock price target?
Price Target
128.23 EUR

According to Wall Street analysts, the average 1-year price target for BIM is 128.23 EUR with a low forecast of 90.9 EUR and a high forecast of 147 EUR.

What is Biomerieux SA's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Biomerieux SA's revenue is 8%. The projected CAGR for the next 3 years is 8%.

What is Biomerieux SA's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Biomerieux SA's operating income is 11%. The projected CAGR for the next 3 years is 14%.

What is Biomerieux SA's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Biomerieux SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

Back to Top